» Articles » PMID: 3902871

An Update on Human Interleukin-1: from Molecular Biology to Clinical Relevance

Overview
Journal J Clin Immunol
Publisher Springer
Date 1985 Sep 1
PMID 3902871
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-1 (IL-1) represents a family of polypeptides with a wide range of biological activities. At least two dissimilar gene products have been cloned; there are probably more. The human IL-1 family plays an important role in the pathogenesis of many diseases and functions as a key mediator of the host response to various infectious, inflammatory, and immunologic challenges. Recombinant mouse (pI 5) and recombinant human (pI 7) IL-1's are being used to confirm the multiple biological properties of IL-1's but considerable investigation is required before the specific activities (biological units per milligram of protein) are established for each human IL-1 form. Some IL-1 biological activities such as the induction of hepatic acute-phase protein synthesis have been demonstrated in invertebrates predating the evolution of lymphocytes. IL-1 is highly inflammatory and increases the concentration of metabolites of arachidonic acid, most notably prostaglandin E2, in brain, muscle, chondrocytes, and synovial fibroblasts. The synthesis of leukotrienes also is involved in the mechanism of its action on certain tissues. The cloning and expression of human IL-1 genes will expand our understanding of IL-1 in various diseases through improved detection systems and the use of cDNA probes; the development of IL-1 antagonists, as well as the use of IL-1 as an immunomodulator, is presently being considered.

Citing Articles

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Kadiu I, Glanzer J, Kipnis J, Gendelman H, Thomas M Neurotox Res. 2005; 8(1-2):25-50.

PMID: 16260384 DOI: 10.1007/BF03033818.


Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Del Zoppo G, Wagner S, Tagaya M Drugs. 1997; 54(1):9-38.

PMID: 9211077 DOI: 10.2165/00003495-199754010-00002.


Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury.

Loesch A, Milner P, Anglin S, Crowe R, Miah S, McEwan J J Anat. 1997; 190 ( Pt 1):93-104.

PMID: 9034885 PMC: 1467587. DOI: 10.1046/j.1469-7580.1997.19010093.x.


Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Fujiwara H, Hamaoka T Immunol Res. 1995; 14(4):271-91.

PMID: 8722044 DOI: 10.1007/BF02935625.


The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma.

Smith D, Kunkel S, Standiford T, Chensue S, Rolfe M, Orringer M Am J Pathol. 1993; 143(3):794-803.

PMID: 8362978 PMC: 1887195.


References
1.
Gery I, Waksman B . Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med. 1972; 136(1):143-55. PMC: 2139186. DOI: 10.1084/jem.136.1.143. View

2.
Lotze M, Frana L, Sharrow S, Robb R, Rosenberg S . In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol. 1985; 134(1):157-66. View

3.
Bevilacqua M, Pober J, Majeau G, COTRAN R, Gimbrone Jr M . Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160(2):618-23. PMC: 2187463. DOI: 10.1084/jem.160.2.618. View

4.
Van Damme J, De Ley M, Opdenakker G, Billiau A, DE SOMER P, Van Beeumen J . Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature. 1985; 314(6008):266-8. DOI: 10.1038/314266a0. View

5.
Libby P, Wyler D, Janicka M, Dinarello C . Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis. 1985; 5(2):186-91. DOI: 10.1161/01.atv.5.2.186. View